Morpholino

MO3-arxa

ID

ZDB-MRPHLNO-130327-1

Name

MO3-arxa

Previous Names

intron 2 – exon 2 junction (1)

Target

arxa (1)

Sequence

5' - GCGTCATATTTACCTGGTGAACACA - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Splice-blocking MO.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO3-arxa

Expressed Gene	Anatomy	Figures
arxa	floor plate pancreatic bud posterior pancreatic bud somite	Fig. 6 , Fig. 7 from Djiotsa et al., 2012
gcga	(not) glucagon secreting cell (not) pancreatic A cell	Fig. 4 from Djiotsa et al., 2012
ghrl	ghrelin secreting cell pancreatic epsilon cell	Fig. 4 from Djiotsa et al., 2012
ins	insulin secreting cell pancreatic B cell	Fig. 4 from Djiotsa et al., 2012
pax4	pancreatic bud posterior pancreatic bud	Fig. 7 from Djiotsa et al., 2012
sst2	D cell somatostatin secreting cell	Fig. 4 from Djiotsa et al., 2012

Phenotype

Phenotype resulting from MO3-arxa

Phenotype	Fish	Figures
glucagon secreting cell decreased amount, abnormal	WT + MO3-arxa	Fig. 4 from Djiotsa et al., 2012
pancreatic A cell decreased amount, abnormal	WT + MO3-arxa	Fig. 4 from Djiotsa et al., 2012

Phenotype of all Fish created by or utilizing MO3-arxa

Phenotype	Fish	Conditions	Figures
pancreatic A cell decreased amount, abnormal	WT + MO3-arxa	standard conditions	Fig. 4 from Djiotsa et al., 2012
glucagon secreting cell decreased amount, abnormal	WT + MO3-arxa	standard conditions	Fig. 4 from Djiotsa et al., 2012
dorsal telencephalon EGFP expression increased amount, abnormal	zf1036Tg + MO3-arxa + MO4-arxa	standard conditions	Fig. 5 from Ishibashi et al., 2015
dorsal telencephalon EGFP expression increased amount, abnormal	zf1038Tg + MO3-arxa + MO4-arxa	standard conditions	Fig. 5 from Ishibashi et al., 2015
ventral thalamus neuron projection EGFP expression spatial pattern, abnormal	zf1039Tg + MO3-arxa + MO4-arxa	standard conditions	Fig. 7 from Ishibashi et al., 2015
telencephalon development disrupted, abnormal	zf1039Tg + MO3-arxa + MO4-arxa	standard conditions	Fig. 7 from Ishibashi et al., 2015
ventral thalamus lateral region EGFP expression increased amount, abnormal	zf1039Tg + MO3-arxa + MO4-arxa	standard conditions	Fig. 5 from Ishibashi et al., 2015
ventral thalamus medial region EGFP expression absent, abnormal	zf1039Tg + MO3-arxa + MO4-arxa	standard conditions	Fig. 5, Fig. 7 from Ishibashi et al., 2015
thalamus development disrupted, abnormal	zf1039Tg + MO3-arxa + MO4-arxa	standard conditions	Fig. 7 from Ishibashi et al., 2015
ventral thalamus neuron projection disorganized, abnormal	zf1039Tg + MO3-arxa + MO4-arxa	standard conditions	Fig. 7 from Ishibashi et al., 2015
pancreatic B cell regeneration increased occurrence, abnormal	ki103Tg; s892Tg; zf5Tg + MO3-arxa	chemical ablation: pancreatic B cell, chemical treatment by environment: metronidazole	Fig. 3 from Lu et al., 2016
glucagon secreting cell ab1-gcg labeling absent, abnormal	ki103Tg; s892Tg; zf5Tg + MO3-arxa	chemical ablation: pancreatic B cell, chemical treatment by environment: metronidazole	Fig. 3 from Lu et al., 2016
pancreatic A cell absent, abnormal	ki103Tg; s892Tg; zf5Tg + MO3-arxa	chemical ablation: pancreatic B cell, chemical treatment by environment: metronidazole	Fig. 3 from Lu et al., 2016

Citations